DK143388A - Anvendelse af substituerede alkylidendithio-bis-(substituerede)-phenoler til fremstilling af farmaceutiske praeparater til inhibering af interleukin-1-frigivelse hos pattedyr - Google Patents

Anvendelse af substituerede alkylidendithio-bis-(substituerede)-phenoler til fremstilling af farmaceutiske praeparater til inhibering af interleukin-1-frigivelse hos pattedyr

Info

Publication number
DK143388A
DK143388A DK143388A DK143388A DK143388A DK 143388 A DK143388 A DK 143388A DK 143388 A DK143388 A DK 143388A DK 143388 A DK143388 A DK 143388A DK 143388 A DK143388 A DK 143388A
Authority
DK
Denmark
Prior art keywords
substituted
alkylidendithio
phenoles
mammals
bis
Prior art date
Application number
DK143388A
Other languages
English (en)
Other versions
DK175801B1 (da
DK143388D0 (da
Inventor
George Ku
Niall Doherty
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK143388D0 publication Critical patent/DK143388D0/da
Publication of DK143388A publication Critical patent/DK143388A/da
Application granted granted Critical
Publication of DK175801B1 publication Critical patent/DK175801B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK198801433A 1987-03-17 1988-03-16 Anvendelse af substituerede alkylidendithio-bis-(substituerede)-phenoler til fremstilling af et lægemiddel til inhibering af interleukin-1-medierede virkninger bortset fra atherosklerose og/eller hyperlipidæmi DK175801B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2658687A 1987-03-17 1987-03-17
US2658687 1987-03-17
US15157288A 1988-02-18 1988-02-18
US15157288 1988-02-18

Publications (3)

Publication Number Publication Date
DK143388D0 DK143388D0 (da) 1988-03-16
DK143388A true DK143388A (da) 1988-09-18
DK175801B1 DK175801B1 (da) 2005-02-28

Family

ID=26701419

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198801433A DK175801B1 (da) 1987-03-17 1988-03-16 Anvendelse af substituerede alkylidendithio-bis-(substituerede)-phenoler til fremstilling af et lægemiddel til inhibering af interleukin-1-medierede virkninger bortset fra atherosklerose og/eller hyperlipidæmi

Country Status (10)

Country Link
EP (1) EP0292660B1 (da)
JP (1) JP2671129B2 (da)
KR (1) KR960005704B1 (da)
AU (1) AU602961B2 (da)
DE (1) DE3869202D1 (da)
DK (1) DK175801B1 (da)
ES (1) ES2039489T3 (da)
GR (1) GR3004108T3 (da)
IE (1) IE60708B1 (da)
PH (1) PH23885A (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4959392A (en) * 1989-07-24 1990-09-25 Merrell Dow Pharmaceuticals Inc. Method of treating diabetes mellitus
AU651873B2 (en) * 1991-03-18 1994-08-04 Merrell Dow Pharmaceuticals Inc. Method of inhibiting the progressive development of diabetes mellitus
FI951367A (fi) * 1994-03-28 1995-09-29 Japan Energy Corp Puriinijohdannaiset ja tulehdustautien tukahduttajat (suppressantit)
EP1695959A1 (en) * 1997-05-14 2006-08-30 Atherogenics, Inc. Compouds and methods for the inhibition of the expression of VCAM-1
US6852878B2 (en) 1998-05-14 2005-02-08 Atherogenics, Inc. Thioketals and thioethers for inhibiting the expression of VCAM-1
US6670398B2 (en) 1997-05-14 2003-12-30 Atherogenics, Inc. Compounds and methods for treating transplant rejection
AU2006202461B2 (en) * 1997-05-14 2009-12-03 Atherogenics, Inc. Compositions and methods for the inhibition of the expression of VCAM-1
EA009987B1 (ru) 1997-05-14 2008-04-28 Атеродженикс, Инк. Производные пробукола для лечения заболеваний, опосредованных vcam-1
EA200000087A1 (ru) 1997-07-01 2000-08-28 Атеродженикс, Инк. Повышение эффективности терапии гиперпролиферативных состояний с помощью антиоксиданта
WO2001077072A2 (en) 2000-04-11 2001-10-18 Atherogenics, Inc. Compounds and methods to increase plasma hdl cholesterol levels and improve hdl functionality
US8252840B2 (en) 2007-03-26 2012-08-28 Salutria Pharmaceuticals Llc Methods of derivatives of probucol for the treatment of type II diabetes
CN108299263B (zh) * 2018-01-30 2020-12-01 北京德默高科医药技术有限公司 一种普罗布考衍生物及其制备方法与应用

Also Published As

Publication number Publication date
DK175801B1 (da) 2005-02-28
AU602961B2 (en) 1990-11-01
IE60708B1 (en) 1994-08-10
EP0292660A3 (en) 1990-03-28
IE880786L (en) 1988-09-17
JPS63258408A (ja) 1988-10-25
ES2039489T3 (es) 1993-10-01
JP2671129B2 (ja) 1997-10-29
EP0292660A2 (en) 1988-11-30
PH23885A (en) 1989-12-18
DE3869202D1 (de) 1992-04-23
EP0292660B1 (en) 1992-03-18
AU1316088A (en) 1988-09-15
KR880010766A (ko) 1988-10-24
DK143388D0 (da) 1988-03-16
GR3004108T3 (da) 1993-03-31
KR960005704B1 (ko) 1996-05-01

Similar Documents

Publication Publication Date Title
DK460283A (da) Fremgangsmaade til fremstilling af topiske farmaceutiske praeparater
DK664387D0 (da) Fremgangsmaade til fremstilling af et anti-inflammatorisk farmaceutisk praeparat
DK143388D0 (da) Anvendelse af substituerede alkylidendithio-bis-(substituerede)-phenoler til fremstilling af farmaceutiske praeparater til inhibering af interleukin-1-frigivelse hos pattedyr
ES550808A0 (es) Procedimiento de obtencion de preparados farmaceuticos de liberacion gradual prolongada
DK280282A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende ergotalkaloider
DK226488A (da) Anvendelse af ace-inhibitorer til fremstilling af farmaceutiske praeparater
DK51282A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater
DK143688D0 (da) Anvendelse af disulfiram og to substituerede phenoler til fremstilling af farmaceutiske praeparater til inhibering af interleukin-1-frigivelse hos pattedyr
DK271588D0 (da) Genteknologisk fremgangsmaade til fremstilling af angiogeniner
NO172351C (no) Fremgangsmaate for fremstilling av glykopeptider
DK100289D0 (da) Fremgangsmaade til fremstilling af n-sulfonylurinstoffer
DK635988D0 (da) 1,3-butandiolacetoacetat-derivater og anvendelse af 1,3-butandiolacetoacetat-forbindelser til fremstilling af farmaceutiske praeparater
DK314988A (da) Fremgangsmaade til fremstilling af 6-deoxyguaninderivater
DK28788D0 (da) Fremgangsmaade til fremstilling af alkansulfonamider
DK574688D0 (da) Fremgangsmaade til fremstilling af propensyrederivater
DK601489A (da) Fremgangsmaade til fremstilling af alkansulfonamider
DK573888A (da) Fremgangsmaade til fremstilling af paramunitetsinducere
DK514785A (da) Fremgangsmaade til fremstilling af derivater af alkoholer
DK498388A (da) Fremgangsmaade til fremstilling af propensyrederivater
DK47681A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater
DK143889A (da) Fremgangsmaade til fremstilling af naphthalenderivater
DK475783D0 (da) Fremgangsmade til fremstilling af farmaceutiske praeparater
DK142788A (da) Fremgangsmaade til fremstilling af chlorerede olefiner
DK68790D0 (da) Anvendelse af tripeptidet l-pyroglutamyl-l-histidylglycin til fremstilling af laegemidler
DK241783A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater

Legal Events

Date Code Title Description
PUP Patent expired